Exploring Concerns Surrounding the VALID Act

The Verifying Accurate Leading-edge IVCT Development (VALID) Act would establish a new category of clinical lab tests comprised of test kits and laboratory developed tests (LDTs), while also granting the FDA authority to review and approve them pre-market. If enacted, this legislation could have a significant impact on the ability of clinical laboratories to provide innovative tests to patients in a timely manner through longstanding CLIA regulations for LDTs.

Please join us for this webinar as we welcome Erin Morton, Senior Vice President, and Meghan Riley, Vice President, of Washington, D.C.-based CRD Associates to provide an overview of the VALID Act and where the legislation currently stands. We will also provide an update on action steps labs can take to oppose this legislation to help ensure they're able to continue providing cutting edge medical care to the patients they serve.